- Andreas Krebs Named President of Europe/Middle East/Africa and Canada -
COLLEGEVILLE, Pa., June 26 /PRNewswire-FirstCall/ -- Wyeth
Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today the
appointment of Andreas Krebs, 50, to President - Europe/Middle East/Africa
and Canada, effective immediately. In this new role, Mr. Krebs will report
to Joseph M. Mahady, President - Wyeth Pharmaceuticals, and Senior Vice
President, Wyeth.
Mr. Krebs joined the Company in July 2003 as General Manager, Wyeth
Germany, and since that time has worked to transform the German affiliate
into one of the fastest growing companies in the market. He serves on the
Board of the VFA (Germany's trade organization for research companies) and
is a member of the Board of Trustees in the Max Planck Institute for
Molecular Biomedicine and the Paul Ehrlich Society for Chemotherapy.
Prior to joining Wyeth, Mr. Krebs was with Bayer for approximately 20
years, where he held a variety of pharmaceutical marketing and sales
leadership positions in Europe, Latin America, Asia and Canada. He holds a
degree in Commercial Management and Business Administration from the
In-House Academy of Woelm Pharma, Eschwege, Germany.
Wyeth is one of the world's largest research-driven pharmaceutical and
health care products companies. It is a leader in the discovery,
development, manufacturing and marketing of pharmaceuticals, vaccines,
biotechnology products, nutritionals and non-prescription medicines that
improve the quality of life for people worldwide. The Company's major
divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort
Dodge Animal Health.
SOURCE Wyeth Pharmaceuticals
 back to top
Related links:
http://www.wyeth.com
CONTACT:
Media, Douglas Petkus, +1-973-660-5218, or
Investors, Justin Victoria, +1-973-660-5340, both of Wyeth
|
